The clinical practical experience and results up to now revealed has promoted using HBOT therapy in patients with cerebrovascular harm and focal cerebrovascular accidents.[104] Having said that, the strength of clinical investigation is limited as a result of shortage of randomized controlled trials.[one zero one]You may properly lessen the costs o